Skip to main navigation Skip to search Skip to main content

The Crux of the Medicine Prices' Controversy in Pakistan

Kah S Lee, Adnan Shahidullah, Syed T R Zaidi, Rahul P Patel, Long C Ming, Muhammad H Tariq, Obaidullah Malik, Muhammad J Farrukh, Ahmad Khan, Siew M Yee, Tahir M Khan

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Drugs are regulated in Pakistan under the Drug Act 1976 and DRAP Act, 2012, under which the sales, storage, and distribution of drugs are regulated at provincial level while the manufacturing (licensing), registration, pricing, import, export, and monitoring of controlled drugs comes under the domain of federal government. The Drug Regulatory Authority of Pakistan (DRAP) established under the DRAP Act 2012 works under the federal government to regulate the aforementioned matters including fixation of prices. Prices are fixed by the Federal government under Section 12 of Drugs Act, 1976 after a recommendation of the Drug Pricing Committee (DPC) constituted the Statutory Regulatory Orders (SRO) on 6th August 2013 under the Cost and Pricing Division, DRAP. DPC is comprised of representatives from provincial health departments, Ministry of Finance and consumer bodies along with stakeholders as observers to proceedings of committee.

Original languageEnglish
Article number504
Pages (from-to)1-4
JournalFrontiers in Pharmacology
Volume8
DOIs
Publication statusPublished - 2 Aug 2017

Fingerprint

Dive into the research topics of 'The Crux of the Medicine Prices' Controversy in Pakistan'. Together they form a unique fingerprint.

Cite this